Long-term survival of systemic sclerosis with pulmonary arterial hypertension patients

被引：0
|
作者：
Sirijanchune, Piyaporn [1 ]
Lhakum, Panomkorn [1 ]
机构：
[1] Chiangrai Prachanukroh Hosp, Internal Med, Chiang Rai, Thailand
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO04-6
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [31] Pulmonary arterial hypertension and systemic sclerosis
    Launay, David
    Humbert, Marc
    Hachulla, Eric
    PRESSE MEDICALE, 2006, 35 (12): : 1929 - 1937
  • [32] Pulmonary arterial hypertension in systemic sclerosis
    Lechartier, Benoit
    Humbert, Marc
    PRESSE MEDICALE, 2021, 50 (01):
  • [33] Pulmonary Arterial Hypertension in the Elderly-Clinical Characteristics and Long-Term Survival
    Shimony, Avi
    Fox, Benjamin D.
    Afilalo, Jonathan
    Rudski, Lawrence G.
    Hirsch, Andrew
    Langleben, David
    LUNG, 2012, 190 (06) : 645 - 649
  • [34] Treatment for children with idiopathic pulmonary arterial hypertension: Long-term survival and outcomes
    Yung, D
    Maislin, G
    Widlitz, A
    Rosenzweig, ESB
    Schmitt, K
    Brady, D
    O'Brien, E
    Kerstein, D
    Horn, EM
    Barst, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 500A - 500A
  • [35] Pulmonary Arterial Hypertension in the Elderly-Clinical Characteristics and Long-Term Survival
    Avi Shimony
    Benjamin D. Fox
    Jonathan Afilalo
    Lawrence G. Rudski
    Andrew Hirsch
    David Langleben
    Lung, 2012, 190 : 645 - 649
  • [36] LONG-TERM SURVIVAL IN SYSTEMIC SCLEROSIS PATIENTS: DEVELOPMENT OF A PREDICTIVE MODEL
    Nihtyanova, Svetlana I.
    Fonseca, Carmen
    Ong, Voon H.
    Denton, Christopher P.
    RHEUMATOLOGY, 2014, 53 : 174 - 174
  • [37] Long-term outcome with first-line bosentan therapy in systemic sclerosis-associated pulmonary arterial hypertension
    Launay, David
    Sitbon, Olivier
    Jais, Xavier
    Yaici, Azzedine
    Le Pavec, Jerome
    Tcherakian, Colas
    Humbert, Marc
    Simonneau, Gerald
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S819 - S819
  • [38] Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)
    Kolstad, Kathleen D.
    Li, Shufeng
    Steen, Virginia
    Chung, Lorinda
    CHEST, 2018, 154 (04) : 862 - 871
  • [39] Long-Term Hepatic Safety of Ambrisentan in Patients With Pulmonary Arterial Hypertension
    Ben-Yehuda, Ori
    Pizzuti, David
    Brown, Andrea
    Littman, Marcus
    Gillies, Hunter
    Henig, Noreen
    Peschel, Tobias
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (01) : 80 - U105
  • [40] Long-term effects with ambrisentan monotherapy in patients with pulmonary arterial hypertension
    文莉
    ChinaMedicalAbstracts(InternalMedicine), 2014, 31 (03) : 160 - 161
12345